Step counting is an important index of motion One of the most diffused wearable systems, designed for this purpose, is the pedometer. The accuracy of commercial pedometers has been tested in literature. Several limits have been found in many commercial systems both in healthy subjects and in disable people. Furthermore, commercial pedometers lack in interoperability. A new wearable system for the step counting has been introduced in this paper. The wearable system is based on a wearable device with a force sensing resistor and a band; it is affixed at the calf gastrocnemius level for the monitoring of the muscular expansion correlated to the gait. The proposed gastrocnemius expansion measurement unit (GEMU) was tested on a three subjects with the Parkinson' s disease at the Level 2 of the Tinetti test of unbalance who performed five repetition of 200 steps with three different instructions (fast, slow). The mean error was lower than 0.5%. Results also showed that GEMU performed better than an accelerometer unit (considered in literature the best solution for this disability). The study showed that GEMU had a high performance in a subject with a pathology (the Parkinson' s disease) causing a high degree of unbalance confounding the motion style and thus pedometers. The next phase will be the optimization of GEMU for long term medical applications at patients' home with the special care to the material and with a comparison to a golden standard.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/IEMBS.2007.4353445 | DOI Listing |
Infect Dis Ther
January 2025
Christian Medical College, Vellore, Tamil Nadu, India.
Tuberculous meningitis (TBM) disables more than a third of its sufferers. Recent research has focused on optimizing the antitubercular regimen, mainly by increasing the dosage of rifampicin. However, pyrazinamide, with higher penetration into the central nervous system, is generally overlooked.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Thoracic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Lung cancer has posed a significant challenge to global health, and related study has been a hot topic in oncology. This article focuses on metabolic reprogramming of lung cancer cells, a process to adapt to energy demands and biosynthetic needs, supporting the proliferation and development of tumor cells. In this study, the latest studies on lung cancer tumor metabolism were reviewed, including the impact of metabolic products and metabolic enzymes on the occurrence and development of lung cancer, as well as the progress in the field of lung cancer treatment targeting relevant metabolic pathways.
View Article and Find Full Text PDFEmerg Med Australas
December 2024
Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Science, Macquarie University, Sydney, New South Wales, Australia.
Equitable access means that timely, sensitive and respectful treatment is offered to all people. Adults with disability access ED care more frequently than the general population. However, in Australia and internationally, people with disability experience poorer healthcare access and outcomes than the general population.
View Article and Find Full Text PDFIEEE Trans Vis Comput Graph
November 2024
Cybersickness continues to bar many individuals from taking full advantage of virtual reality (VR) technology. Previous work has established that navigating virtual terrain with elevation changes poses a significant risk in this regard. In this paper, we investigate the effectiveness of three cybersickness reduction strategies on users performing a navigation task across virtual elevation-altering terrain.
View Article and Find Full Text PDFMater Horiz
October 2024
College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Med-X Center for Materials, Sichuan University, Chengdu 610065, P. R. China.
Osteoarthritis (OA), which disables articular cartilage, affects millions of people. The self-healing capacity is inhibited by internal oxidative stress and external lubrication deficiency and enzymatic degradation. To overcome these challenges, a tailored cartilage-armor is designed to ameliorate the inflamed cartilage, which is implemented by a novel collagen type II (Col II)-binding peptide conjugated zwitterionic polymer (PSB--PColBP, PSP).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!